AdaptHealth Statistics
Total Valuation
AdaptHealth has a market cap or net worth of $1.28 billion. The enterprise value is $3.36 billion.
Important Dates
The last earnings date was Tuesday, November 5, 2024, before market open.
Earnings Date | Nov 5, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AdaptHealth has 131.62 million shares outstanding. The number of shares has decreased by -0.81% in one year.
Current Share Class | 131.62M |
Shares Outstanding | 131.62M |
Shares Change (YoY) | -0.81% |
Shares Change (QoQ) | +0.37% |
Owned by Insiders (%) | 11.19% |
Owned by Institutions (%) | 73.07% |
Float | 78.37M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 10.12 |
PS Ratio | 0.40 |
Forward PS | 0.37 |
PB Ratio | 0.84 |
P/TBV Ratio | n/a |
P/FCF Ratio | 5.58 |
P/OCF Ratio | 2.34 |
PEG Ratio | 1.39 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 5.03, with an EV/FCF ratio of 14.67.
EV / Earnings | n/a |
EV / Sales | 1.03 |
EV / EBITDA | 5.03 |
EV / EBIT | 11.13 |
EV / FCF | 14.67 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 1.43.
Current Ratio | 1.24 |
Quick Ratio | 0.91 |
Debt / Equity | 1.43 |
Debt / EBITDA | 2.98 |
Debt / FCF | 9.50 |
Interest Coverage | 2.32 |
Financial Efficiency
Return on equity (ROE) is -12.88% and return on invested capital (ROIC) is 4.88%.
Return on Equity (ROE) | -12.88% |
Return on Assets (ROA) | 4.11% |
Return on Capital (ROIC) | 4.88% |
Revenue Per Employee | $304,913 |
Profits Per Employee | -$20,351 |
Employee Count | 10,700 |
Asset Turnover | 0.71 |
Inventory Turnover | 21.22 |
Taxes
In the past 12 months, AdaptHealth has paid $3.82 million in taxes.
Income Tax | 3.82M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.95% in the last 52 weeks. The beta is 1.13, so AdaptHealth's price volatility has been higher than the market average.
Beta (5Y) | 1.13 |
52-Week Price Change | +13.95% |
50-Day Moving Average | 10.53 |
200-Day Moving Average | 10.23 |
Relative Strength Index (RSI) | 42.86 |
Average Volume (20 Days) | 1,058,604 |
Short Selling Information
The latest short interest is 10.39 million, so 7.89% of the outstanding shares have been sold short.
Short Interest | 10.39M |
Short Previous Month | 10.14M |
Short % of Shares Out | 7.89% |
Short % of Float | 13.26% |
Short Ratio (days to cover) | 18.50 |
Income Statement
In the last 12 months, AdaptHealth had revenue of $3.26 billion and -$217.76 million in losses. Loss per share was -$1.65.
Revenue | 3.26B |
Gross Profit | 611.45M |
Operating Income | 302.22M |
Pretax Income | -730.11M |
Net Income | -217.76M |
EBITDA | 669.38M |
EBIT | 302.22M |
Loss Per Share | -$1.65 |
Full Income Statement Balance Sheet
The company has $102.30 million in cash and $2.18 billion in debt, giving a net cash position of -$2.08 billion or -$15.78 per share.
Cash & Cash Equivalents | 102.30M |
Total Debt | 2.18B |
Net Cash | -2.08B |
Net Cash Per Share | -$15.78 |
Equity (Book Value) | 1.52B |
Book Value Per Share | 11.52 |
Working Capital | 130.77M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $546.69 million and capital expenditures -$317.37 million, giving a free cash flow of $229.32 million.
Operating Cash Flow | 546.69M |
Capital Expenditures | -317.37M |
Free Cash Flow | 229.32M |
FCF Per Share | $1.74 |
Full Cash Flow Statement Margins
Gross margin is 18.74%, with operating and profit margins of 9.26% and -6.57%.
Gross Margin | 18.74% |
Operating Margin | 9.26% |
Pretax Margin | -6.33% |
Profit Margin | -6.57% |
EBITDA Margin | 20.52% |
EBIT Margin | 9.26% |
FCF Margin | 5.10% |
Dividends & Yields
AdaptHealth does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.81% |
Shareholder Yield | 0.81% |
Earnings Yield | -17.02% |
FCF Yield | 17.93% |
Dividend Details Analyst Forecast
The average price target for AdaptHealth is $12.40, which is 27.57% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.40 |
Price Target Difference | 27.57% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AdaptHealth has an Altman Z-Score of 1.05 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.05 |
Piotroski F-Score | 6 |